US-based Walgreens is expanding its micro-fulfillment centers to support retail pharmacies, using robotics to manage prescription fills.

This allows pharmacy staff to focus on clinical services like vaccinations and consultations.

By the end of 2025, Walgreens plans to have 11 centers serving over 5,000 stores, up from 4,800 in February.

These centers currently process 40% of prescriptions at supported locations, totaling 16 million prescriptions monthly.

The company reports US$500 million in savings from reduced inventory and improved efficiency. Stores with micro-fulfillment support administer 40% more vaccines than those without.

However, challenges remain, including robotic errors and customer complaints about delayed or incomplete prescriptions.

🔗 Source: CNBC

🧠 Food for thought

1️⃣ Pharmacy automation represents a decades-long evolution, not a sudden shift

Walgreens’ automation push follows a longer trajectory of pharmacy technology adoption that began decades ago, not just a response to recent pressures.

The earliest discussions about computerization in medicine date back to the 1960s, when medical professionals first recognized technology’s potential to reduce errors and improve decision-making1.

UCSF’s groundbreaking automated pharmacy system, which won recognition in 2011, demonstrated that robotics could assemble over 1.5 million medication packages without errors while allowing pharmacists to focus more on patient care2.

This historical context explains why Walgreens initially implemented micro-fulfillment centers in 2021, paused for refinement, and is now confidently expanding. They are building on accumulated industry knowledge rather than experimenting blindly.

The company’s goal to have robots handling 50% of prescription volume by 2025 represents the culmination of pharmacy automation’s natural evolution, not a radical departure from industry norms3.

2️⃣ The data economics of pharmacy automation extend beyond labor savings

While reducing labor costs is an obvious benefit, the financial impact of Walgreens’ automation strategy reveals more complex economic advantages that investors might overlook.